Clinical Trial

Probiotics Regulate Intestinal Health and Alleviate Anxiety

Completed
View on ClinicalTrials.gov →
Summary
This study is a randomized, double-blind, placebo-controlled trial aimed primarily at investigating the effects of Weizmannia coagulans BC99 on alleviating anxiety and depression and the gut microbiota.
Trial Details
NCT Number NCT07353320
Lead Sponsor Wecare Probiotics Co., Ltd.
Conditions Anxiety Depression
Enrollment 79 participants
Start Date 2024-04-10
Primary Completion 2024-06-05 (estimated)
Study Completion 2025-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-20